These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 20125017)

  • 81. The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury.
    Vogel T; Brockmann JG; Coussios C; Friend PJ
    Transplant Rev (Orlando); 2012 Apr; 26(2):156-62. PubMed ID: 22459038
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Improving donor heart preservation ex vivo].
    Ferrera R; Benhabbouche S
    Bull Acad Natl Med; 2011; 195(4-5):861-78; discussion 878-81. PubMed ID: 22375357
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [How to increase availability of grafts in lung transplantion: ex vivo lung reconditioning - cardiac death donors - high emergency list].
    Souilamas R; Souilamas J; Saueressig M; Pison C; Briot R
    Rev Pneumol Clin; 2010 Feb; 67(1):50-6. PubMed ID: 21353972
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Donation after circulatory death: current status.
    Neyrinck A; Van Raemdonck D; Monbaliu D
    Curr Opin Anaesthesiol; 2013 Jun; 26(3):382-90. PubMed ID: 23632566
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Lung in a Box: Ex Vivo Lung Transplantation.
    Cotter EKH; Banayan JM; Song TH; Chaney MA; Ko H; Cantu E; Diamond J; Weiss SJ; Cypel M; Keshavjee S
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1971-1981. PubMed ID: 29449154
    [No Abstract]   [Full Text] [Related]  

  • 86. Beware Cold Agglutinins in Organ Donors! Ex Vivo Lung Perfusion From an Uncontrolled Donation After Circulatory-Determination-of-Death Donor With a Cold Agglutinin: A Case Report.
    Venkataraman A; Blackwell JW; Funkhouser WK; Birchard KR; Beamer SE; Simmons WT; Randell SH; Egan TM
    Transplant Proc; 2017 Sep; 49(7):1678-1681. PubMed ID: 28838463
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Transplantation of initially rejected donor lungs after ex vivo lung perfusion.
    Wallinder A; Ricksten SE; Hansson C; Riise GC; Silverborn M; Liden H; Olausson M; Dellgren G
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1222-8. PubMed ID: 22995721
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Ex Vivo Lung Perfusion: Establishment and Operationalization in Iran.
    Shafaghi S; Abbasi Dezfuli A; Ansari Aval Z; Sheikhy K; Farzanegan B; Mortaz E; Emami H; Aigner C; Hosseini-Baharanchi FS; Najafizadeh K
    Exp Clin Transplant; 2017 Feb; 15(1):82-88. PubMed ID: 27759556
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues.
    Dikdan GS; Mora-Esteves C; Koneru B
    Transplantation; 2012 Sep; 94(5):425-41. PubMed ID: 22892991
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Ex Vivo Lung Perfusion: A Review of Research and Clinical Practices.
    Chan PG; Kumar A; Subramaniam K; Sanchez PG
    Semin Cardiothorac Vasc Anesth; 2020 Mar; 24(1):34-44. PubMed ID: 32036756
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effect of donor preservation solution and survival in lung transplantation.
    Marasco SF; Bailey M; McGlade D; Snell G; Westall G; Oto T; Pilcher D
    J Heart Lung Transplant; 2011 Apr; 30(4):414-9. PubMed ID: 21131216
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Changing paradigms in organ preservation and resuscitation.
    Ali F; Dua A; Cronin DC
    Curr Opin Organ Transplant; 2015 Apr; 20(2):152-8. PubMed ID: 25719899
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pumping new life into old ideas: Preservation and rehabilitation of the liver using ex situ machine perfusion.
    Raigani S; De Vries RJ; Uygun K; Yeh H
    Artif Organs; 2020 Feb; 44(2):123-128. PubMed ID: 31691326
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Kidney preservation: from 'do no further harm' to 'opportunity to recover'.
    van Heurn E
    Curr Opin Organ Transplant; 2011 Apr; 16(2):149-50. PubMed ID: 21415816
    [No Abstract]   [Full Text] [Related]  

  • 95. Extended criteria donor lung reconditioning with the organ care system lung: a single institution experience.
    Schiavon M; Faggi G; Rebusso A; Lunardi F; Comacchio G; Di Gregorio G; Feltracco P; Gregori D; Calabrese F; Marulli G; Cozzi E; Federico R
    Transpl Int; 2019 Feb; 32(2):131-140. PubMed ID: 30350894
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The contribution of airway and lung tissue ischemia to primary graft dysfunction.
    Diamond JM; Christie JD
    Curr Opin Organ Transplant; 2010 Oct; 15(5):552-7. PubMed ID: 20693898
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A randomized, placebo-controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation.
    Herrington CS; Prekker ME; Arrington AK; Susanto D; Baltzell JW; Studenski LL; Radosevich DM; Kelly RF; Shumway SJ; Hertz MI; Bittner HB; Dahlberg PS
    Clin Transplant; 2011; 25(1):90-6. PubMed ID: 20731686
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Combating Donor Organ Shortage: Organ Care System Prolonging Organ Storage Time and Improving the Outcome of Heart Transplantations.
    Sunjaya AF; Sunjaya AP
    Cardiovasc Ther; 2019; 2019():9482797. PubMed ID: 31772620
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Warm retrograde perfusion can remove more fat from lung grafts with fat embolism in a porcine model.
    Irie M; Otani S; Kurosaki T; Tanaka S; Ohki T; Miyoshi K; Sugimoto S; Yamane M; Oto T; Toyooka S
    Gen Thorac Cardiovasc Surg; 2020 Apr; 68(4):363-369. PubMed ID: 31720984
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Strategies for safe donor expansion: donor management, donations after cardiac death, ex-vivo lung perfusion.
    Cypel M; Keshavjee S
    Curr Opin Organ Transplant; 2013 Oct; 18(5):513-7. PubMed ID: 23995370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.